Thomas Jefferson University
Clinical trials sponsored by Thomas Jefferson University, explained in plain language.
-
Sugar water injection may fix leaky lungs after surgery
Disease control Not yet recruitingAfter lung surgery, some patients have a persistent air leak that requires a chest tube for days. This study tests whether injecting a sugar water solution (dextrose) through the tube can seal the leak faster than standard drainage alone. About 80 adults with a stubborn air leak …
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 23, 2026 12:00 UTC
-
New combo therapy targets high-risk MDS in early trial
Disease control Not yet recruitingThis study tests a new two-drug combination (pacritinib plus azacitidine) for people with moderate to very high risk myelodysplastic syndrome (MDS), a bone marrow disorder. The first part finds the safest dose of pacritinib, and the second part checks how well the combination wor…
Phase: PHASE1, PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 15, 2026 18:56 UTC
-
Sound waves and bubbles take on stubborn joint infections
Disease control Not yet recruitingThis study tests a new way to treat infected knee replacements. About 100 adults having surgery for an infected knee will be randomly assigned to receive either standard care or standard care plus an extra treatment. The extra treatment involves injecting antibiotics along with s…
Phase: PHASE2 • Sponsor: Thomas Jefferson University • Aim: Disease control
Last updated Jun 09, 2026 12:09 UTC
-
Can an ultrasound rival MRI for prostate cancer detection?
Diagnosis Not yet recruitingThis study compares a special ultrasound (mp-US) with contrast dye to standard MRI for finding prostate cancer. About 300 men scheduled for a biopsy will get both scans to see if the ultrasound can guide biopsies just as well as MRI. The goal is to offer a simpler, cheaper option…
Phase: PHASE3 • Sponsor: Thomas Jefferson University • Aim: Diagnosis
Last updated Jun 10, 2026 13:26 UTC
-
Timing is everything: can early ketamine halt stubborn seizures?
Symptom relief Not yet recruitingThis study looks at whether giving the drug ketamine earlier, along with standard midazolam, can stop seizures faster in adults with refractory status epilepticus (seizures that don't stop with usual medicines). The trial will involve 50 adults who have not responded to first- an…
Phase: PHASE4 • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 22, 2026 12:05 UTC
-
Tailored PT after hernia surgery may boost recovery and cut costs
Symptom relief Not yet recruitingThis study tests if a personalized physical therapy program helps people recover better after ventral hernia repair. About 100 adults aged 18-75 will be randomly assigned to either standard care or a tailored 10-week PT plan. Researchers will measure pain, quality of life, compli…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Symptom relief
Last updated Jun 09, 2026 12:10 UTC
-
Can a smartphone app and coach boost breastfeeding in india?
Knowledge-focused Not yet recruitingThis study tests a program called BEST4Baby, which uses trained peer counselors and a mobile health app to support new mothers in India with breastfeeding. About 336 pregnant women will be split into two groups: one gets the extra support, the other gets usual care. Researchers w…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated Jun 22, 2026 11:57 UTC
-
New program aims to catch dementia sooner in primary care
Knowledge-focused Not yet recruitingThis study tests a program called Improving Dementia Care (IDC) to help primary care doctors identify dementia in patients who have memory concerns but no prior diagnosis. About 80 adults with mild cognitive issues will take part. The goal is to see if the program leads to more d…
Phase: NA • Sponsor: Thomas Jefferson University • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC